Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL
Literature
Read More
Pro-Tumorigenic Mechanisms of M2 Tumor-Associated Macrophages in Triple-Negative Breast Cancer
Literature
Read More
NeoGenomics Launches Immuno-Oncology Companion Diagnostic Test for Triple Negative Breast Cancer in Conjunction with FDA Approval for TECENTRIQ(R)
Press Release
Read More
NeoGenomics To Present At 39th Annual Cowen and Company Health Care Conference
Press Release
Read More
NeoGenomics Reports Record Revenue of $76 Million with 17% Organic Revenue Growth in the Fourth Quarter
Press Release
Read More
Immunohistochemical detection of PD-L1 among diverse human neoplasms in a reference laboratory: observations based upon 62,896 cases
Literature
Read More
Aggressive B cell lymphomas in the 2017 revised WHO classification of tumors of hematopoietic and lymphoid tissues
Literature
Read More
NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2018 Earnings Release for February 19, 2019
Press Release
Read More